| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6825855 | Schizophrenia Research | 2013 | 8 Pages |
Abstract
Our results suggest that adenosine modulator adjuvant therapy is more beneficial in overall psychopathology (especially positive symptoms) in schizophrenia and in treating mania episodes of BD in comparison to placebo. The limited sample size of available studies suggests that more research should be done to evaluate both efficacy and tolerability of these medications.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Tomoya Hirota, Taro Kishi,